164 related articles for article (PubMed ID: 8996538)
1. Amputation and dexniguldipine as treatment for canine appendicular osteosarcoma.
Hahn KA; Legendre AM; Schuller HM
J Cancer Res Clin Oncol; 1997; 123(1):34-8. PubMed ID: 8996538
[TBL] [Abstract][Full Text] [Related]
2. Canine osteosarcoma: amputation and chemoimmunotherapy.
MacEwen EG; Kurzman ID
Vet Clin North Am Small Anim Pract; 1996 Jan; 26(1):123-33. PubMed ID: 8825571
[TBL] [Abstract][Full Text] [Related]
3. Canine osteosarcoma: amputation and chemotherapy.
Berg J
Vet Clin North Am Small Anim Pract; 1996 Jan; 26(1):111-21. PubMed ID: 8825570
[TBL] [Abstract][Full Text] [Related]
4. Use of cisplatin for treatment of appendicular osteosarcoma in dogs.
Shapiro W; Fossum TW; Kitchell BE; Couto CG; Theilen GH
J Am Vet Med Assoc; 1988 Feb; 192(4):507-11. PubMed ID: 3163684
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of survival times after limb amputation, with and without subsequent administration of cisplatin, for treatment of appendicular osteosarcoma in dogs: 30 cases (1979-1990).
Thompson JP; Fugent MJ
J Am Vet Med Assoc; 1992 Feb; 200(4):531-3. PubMed ID: 1559895
[TBL] [Abstract][Full Text] [Related]
6. Canine osteosarcoma. Treatment by amputation versus amputation and adjuvant chemotherapy using doxorubicin and cisplatin.
Mauldin GN; Matus RE; Withrow SJ; Patnaik AK
J Vet Intern Med; 1988; 2(4):177-80. PubMed ID: 3230557
[TBL] [Abstract][Full Text] [Related]
7. Treatment of dogs with osteosarcoma by administration of cisplatin after amputation or limb-sparing surgery: 22 cases (1987-1990).
Berg J; Weinstein MJ; Schelling SH; Rand WM
J Am Vet Med Assoc; 1992 Jun; 200(12):2005-8. PubMed ID: 1639715
[TBL] [Abstract][Full Text] [Related]
8. Amputation and cisplatin for treatment of canine osteosarcoma.
Straw RC; Withrow SJ; Richter SL; Powers BE; Klein MK; Postorino NC; LaRue SM; Ogilvie GK; Vail DM; Morrison WB
J Vet Intern Med; 1991; 5(4):205-10. PubMed ID: 1941754
[TBL] [Abstract][Full Text] [Related]
9. Use of single-agent carboplatin as adjuvant or neoadjuvant therapy in conjunction with amputation for appendicular osteosarcoma in dogs.
Phillips B; Powers BE; Dernell WS; Straw RC; Khanna C; Hogge GS; Vail DM
J Am Anim Hosp Assoc; 2009; 45(1):33-8. PubMed ID: 19122062
[TBL] [Abstract][Full Text] [Related]
10. Proximal radial and distal humeral osteosarcoma in 12 dogs.
Liptak JM; Dernell WS; Straw RC; Rizzo SA; Lafferty MH; Withrow SJ
J Am Anim Hosp Assoc; 2004; 40(6):461-7. PubMed ID: 15533966
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of metronomic cyclophosphamide chemotherapy as maintenance treatment for dogs with appendicular osteosarcoma following limb amputation and carboplatin chemotherapy.
Matsuyama A; Schott CR; Wood GA; Richardson D; Woods JP; Mutsaers AJ
J Am Vet Med Assoc; 2018 Jun; 252(11):1377-1383. PubMed ID: 29772973
[TBL] [Abstract][Full Text] [Related]
12. Osteosarcoma in a 6-year-old Newfoundland dog: limb-sparing surgery and cisplatin chemotherapy.
Dawe J
Can Vet J; 2007 Nov; 48(11):1169-71. PubMed ID: 18050799
[TBL] [Abstract][Full Text] [Related]
13. Bone allografts and adjuvant cisplatin for the treatment of canine appendicular osteosarcoma in 18 dogs.
Morello E; Buracco P; Martano M; Peirone B; Capurro C; Valazza A; Cotto D; Ferracini R; Sora M
J Small Anim Pract; 2001 Feb; 42(2):61-6. PubMed ID: 11263699
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of protein-kinase-C--dependent cell proliferation of human lung cancer cell lines by the dihydropyridine dexniguldipine.
Schuller HM; Orloff M; Reznik GK
J Cancer Res Clin Oncol; 1994; 120(6):354-8. PubMed ID: 8138560
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of serum alkaline phosphatase activity in canine appendicular osteosarcoma.
Garzotto CK; Berg J; Hoffmann WE; Rand WM
J Vet Intern Med; 2000; 14(6):587-92. PubMed ID: 11110379
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of P16 expression in canine appendicular osteosarcoma.
Murphy BG; Mok MY; York D; Rebhun R; Woolard KD; Hillman C; Dickinson P; Skorupski K
BMC Vet Res; 2017 Jun; 13(1):189. PubMed ID: 28633676
[TBL] [Abstract][Full Text] [Related]
17. Toxicity and efficacy of cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma.
Chun R; Garrett LD; Henry C; Wall M; Smith A; Azene NM
J Am Anim Hosp Assoc; 2005; 41(6):382-7. PubMed ID: 16267062
[TBL] [Abstract][Full Text] [Related]
18. STEALTH liposome-encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trial.
Vail DM; Kurzman ID; Glawe PC; O'Brien MG; Chun R; Garrett LD; Obradovich JE; Fred RM; Khanna C; Colbern GT; Working PK
Cancer Chemother Pharmacol; 2002 Aug; 50(2):131-6. PubMed ID: 12172978
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma: a pilot study.
Chun R; Kurzman ID; Couto CG; Klausner J; Henry C; MacEwen EG
J Vet Intern Med; 2000; 14(5):495-8. PubMed ID: 11012111
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of circulating microRNA-214 and -126 in dogs with appendicular osteosarcoma receiving amputation and chemotherapy.
Heishima K; Meuten T; Yoshida K; Mori T; Thamm DH
BMC Vet Res; 2019 Jan; 15(1):39. PubMed ID: 30683101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
